The global market for Roflumilast API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Roflumilast API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Roflumilast API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Roflumilast API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Roflumilast API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Roflumilast API players cover Huateng Pharma, Chongqing Huapont Pharmaceutical, Interquim SA, Veranova and ALP Pharm, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Roflumilast API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Roflumilast API market, with both quantitative and qualitative data, to help readers understand how the Roflumilast API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Roflumilast API market and forecasts the market size by Purity (0.98, 0.99 and Others), by Application (Medical Pharmaceutical and Scientific Research.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
0.98
0.99
Others
Segmentation by application
Medical Pharmaceutical
Scientific Research
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Huateng Pharma
Chongqing Huapont Pharmaceutical
Interquim SA
Veranova
ALP Pharm
Aspire Lifesciences
Aurobindo Pharma Limited
Glenmark Pharmaceuticals
MSN Laboratories
Melody Healthcare
Mylan Inc
Torrent Pharmaceuticals
Chapter Introduction
Chapter 1: Scope of Roflumilast API, Research Methodology, etc.
Chapter 2: Executive Summary, global Roflumilast API market size (sales and revenue) and CAGR, Roflumilast API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Roflumilast API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Roflumilast API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Roflumilast API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Huateng Pharma, Chongqing Huapont Pharmaceutical, Interquim SA, Veranova, ALP Pharm, Aspire Lifesciences, Aurobindo Pharma Limited, Glenmark Pharmaceuticals and MSN Laboratories, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Roflumilast API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Roflumilast API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Roflumilast API by Country/Region, 2017, 2022 & 2028
2.2 Roflumilast API Segment by Purity
2.2.1 0.98
2.2.2 0.99
2.2.3 Others
2.3 Roflumilast API Sales by Purity
2.3.1 Global Roflumilast API Sales Market Share by Purity (2017-2022)
2.3.2 Global Roflumilast API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Roflumilast API Sale Price by Purity (2017-2022)
2.4 Roflumilast API Segment by Application
2.4.1 Medical Pharmaceutical
2.4.2 Scientific Research
2.5 Roflumilast API Sales by Application
2.5.1 Global Roflumilast API Sale Market Share by Application (2017-2022)
2.5.2 Global Roflumilast API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Roflumilast API Sale Price by Application (2017-2022)
3 Global Roflumilast API by Company
3.1 Global Roflumilast API Breakdown Data by Company
3.1.1 Global Roflumilast API Annual Sales by Company (2020-2022)
3.1.2 Global Roflumilast API Sales Market Share by Company (2020-2022)
3.2 Global Roflumilast API Annual Revenue by Company (2020-2022)
3.2.1 Global Roflumilast API Revenue by Company (2020-2022)
3.2.2 Global Roflumilast API Revenue Market Share by Company (2020-2022)
3.3 Global Roflumilast API Sale Price by Company
3.4 Key Manufacturers Roflumilast API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Roflumilast API Product Location Distribution
3.4.2 Players Roflumilast API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Roflumilast API by Geographic Region
4.1 World Historic Roflumilast API Market Size by Geographic Region (2017-2022)
4.1.1 Global Roflumilast API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Roflumilast API Annual Revenue by Geographic Region
4.2 World Historic Roflumilast API Market Size by Country/Region (2017-2022)
4.2.1 Global Roflumilast API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Roflumilast API Annual Revenue by Country/Region
4.3 Americas Roflumilast API Sales Growth
4.4 APAC Roflumilast API Sales Growth
4.5 Europe Roflumilast API Sales Growth
4.6 Middle East & Africa Roflumilast API Sales Growth
5 Americas
5.1 Americas Roflumilast API Sales by Country
5.1.1 Americas Roflumilast API Sales by Country (2017-2022)
5.1.2 Americas Roflumilast API Revenue by Country (2017-2022)
5.2 Americas Roflumilast API Sales by Purity
5.3 Americas Roflumilast API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Roflumilast API Sales by Region
6.1.1 APAC Roflumilast API Sales by Region (2017-2022)
6.1.2 APAC Roflumilast API Revenue by Region (2017-2022)
6.2 APAC Roflumilast API Sales by Purity
6.3 APAC Roflumilast API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Roflumilast API by Country
7.1.1 Europe Roflumilast API Sales by Country (2017-2022)
7.1.2 Europe Roflumilast API Revenue by Country (2017-2022)
7.2 Europe Roflumilast API Sales by Purity
7.3 Europe Roflumilast API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Roflumilast API by Country
8.1.1 Middle East & Africa Roflumilast API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Roflumilast API Revenue by Country (2017-2022)
8.2 Middle East & Africa Roflumilast API Sales by Purity
8.3 Middle East & Africa Roflumilast API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Roflumilast API
10.3 Manufacturing Process Analysis of Roflumilast API
10.4 Industry Chain Structure of Roflumilast API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Roflumilast API Distributors
11.3 Roflumilast API Customer
12 World Forecast Review for Roflumilast API by Geographic Region
12.1 Global Roflumilast API Market Size Forecast by Region
12.1.1 Global Roflumilast API Forecast by Region (2023-2028)
12.1.2 Global Roflumilast API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Roflumilast API Forecast by Purity
12.7 Global Roflumilast API Forecast by Application
13 Key Players Analysis
13.1 Huateng Pharma
13.1.1 Huateng Pharma Company Information
13.1.2 Huateng Pharma Roflumilast API Product Offered
13.1.3 Huateng Pharma Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Huateng Pharma Main Business Overview
13.1.5 Huateng Pharma Latest Developments
13.2 Chongqing Huapont Pharmaceutical
13.2.1 Chongqing Huapont Pharmaceutical Company Information
13.2.2 Chongqing Huapont Pharmaceutical Roflumilast API Product Offered
13.2.3 Chongqing Huapont Pharmaceutical Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Chongqing Huapont Pharmaceutical Main Business Overview
13.2.5 Chongqing Huapont Pharmaceutical Latest Developments
13.3 Interquim SA
13.3.1 Interquim SA Company Information
13.3.2 Interquim SA Roflumilast API Product Offered
13.3.3 Interquim SA Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Interquim SA Main Business Overview
13.3.5 Interquim SA Latest Developments
13.4 Veranova
13.4.1 Veranova Company Information
13.4.2 Veranova Roflumilast API Product Offered
13.4.3 Veranova Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Veranova Main Business Overview
13.4.5 Veranova Latest Developments
13.5 ALP Pharm
13.5.1 ALP Pharm Company Information
13.5.2 ALP Pharm Roflumilast API Product Offered
13.5.3 ALP Pharm Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 ALP Pharm Main Business Overview
13.5.5 ALP Pharm Latest Developments
13.6 Aspire Lifesciences
13.6.1 Aspire Lifesciences Company Information
13.6.2 Aspire Lifesciences Roflumilast API Product Offered
13.6.3 Aspire Lifesciences Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Aspire Lifesciences Main Business Overview
13.6.5 Aspire Lifesciences Latest Developments
13.7 Aurobindo Pharma Limited
13.7.1 Aurobindo Pharma Limited Company Information
13.7.2 Aurobindo Pharma Limited Roflumilast API Product Offered
13.7.3 Aurobindo Pharma Limited Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aurobindo Pharma Limited Main Business Overview
13.7.5 Aurobindo Pharma Limited Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Roflumilast API Product Offered
13.8.3 Glenmark Pharmaceuticals Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 MSN Laboratories
13.9.1 MSN Laboratories Company Information
13.9.2 MSN Laboratories Roflumilast API Product Offered
13.9.3 MSN Laboratories Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 MSN Laboratories Main Business Overview
13.9.5 MSN Laboratories Latest Developments
13.10 Melody Healthcare
13.10.1 Melody Healthcare Company Information
13.10.2 Melody Healthcare Roflumilast API Product Offered
13.10.3 Melody Healthcare Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Melody Healthcare Main Business Overview
13.10.5 Melody Healthcare Latest Developments
13.11 Mylan Inc
13.11.1 Mylan Inc Company Information
13.11.2 Mylan Inc Roflumilast API Product Offered
13.11.3 Mylan Inc Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Mylan Inc Main Business Overview
13.11.5 Mylan Inc Latest Developments
13.12 Torrent Pharmaceuticals
13.12.1 Torrent Pharmaceuticals Company Information
13.12.2 Torrent Pharmaceuticals Roflumilast API Product Offered
13.12.3 Torrent Pharmaceuticals Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Torrent Pharmaceuticals Main Business Overview
13.12.5 Torrent Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Roflumilast API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Roflumilast API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.98
Table 4. Major Players of 0.99
Table 5. Major Players of Others
Table 6. Global Roflumilast API Sales by Purity (2017-2022) & (Tons)
Table 7. Global Roflumilast API Sales Market Share by Purity (2017-2022)
Table 8. Global Roflumilast API Revenue by Purity (2017-2022) & ($ million)
Table 9. Global Roflumilast API Revenue Market Share by Purity (2017-2022)
Table 10. Global Roflumilast API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 11. Global Roflumilast API Sales by Application (2017-2022) & (Tons)
Table 12. Global Roflumilast API Sales Market Share by Application (2017-2022)
Table 13. Global Roflumilast API Revenue by Application (2017-2022)
Table 14. Global Roflumilast API Revenue Market Share by Application (2017-2022)
Table 15. Global Roflumilast API Sale Price by Application (2017-2022) & (US$/Kg)
Table 16. Global Roflumilast API Sales by Company (2020-2022) & (Tons)
Table 17. Global Roflumilast API Sales Market Share by Company (2020-2022)
Table 18. Global Roflumilast API Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Roflumilast API Revenue Market Share by Company (2020-2022)
Table 20. Global Roflumilast API Sale Price by Company (2020-2022) & (US$/Kg)
Table 21. Key Manufacturers Roflumilast API Producing Area Distribution and Sales Area
Table 22. Players Roflumilast API Products Offered
Table 23. Roflumilast API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Roflumilast API Sales by Geographic Region (2017-2022) & (Tons)
Table 27. Global Roflumilast API Sales Market Share Geographic Region (2017-2022)
Table 28. Global Roflumilast API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Roflumilast API Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Roflumilast API Sales by Country/Region (2017-2022) & (Tons)
Table 31. Global Roflumilast API Sales Market Share by Country/Region (2017-2022)
Table 32. Global Roflumilast API Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Roflumilast API Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Roflumilast API Sales by Country (2017-2022) & (Tons)
Table 35. Americas Roflumilast API Sales Market Share by Country (2017-2022)
Table 36. Americas Roflumilast API Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Roflumilast API Revenue Market Share by Country (2017-2022)
Table 38. Americas Roflumilast API Sales by Type (2017-2022) & (Tons)
Table 39. Americas Roflumilast API Sales Market Share by Purity (2017-2022)
Table 40. Americas Roflumilast API Sales by Application (2017-2022) & (Tons)
Table 41. Americas Roflumilast API Sales Market Share by Application (2017-2022)
Table 42. APAC Roflumilast API Sales by Region (2017-2022) & (Tons)
Table 43. APAC Roflumilast API Sales Market Share by Region (2017-2022)
Table 44. APAC Roflumilast API Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Roflumilast API Revenue Market Share by Region (2017-2022)
Table 46. APAC Roflumilast API Sales by Purity (2017-2022) & (Tons)
Table 47. APAC Roflumilast API Sales Market Share by Purity (2017-2022)
Table 48. APAC Roflumilast API Sales by Application (2017-2022) & (Tons)
Table 49. APAC Roflumilast API Sales Market Share by Application (2017-2022)
Table 50. Europe Roflumilast API Sales by Country (2017-2022) & (Tons)
Table 51. Europe Roflumilast API Sales Market Share by Country (2017-2022)
Table 52. Europe Roflumilast API Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Roflumilast API Revenue Market Share by Country (2017-2022)
Table 54. Europe Roflumilast API Sales by Type (2017-2022) & (Tons)
Table 55. Europe Roflumilast API Sales Market Share by Purity (2017-2022)
Table 56. Europe Roflumilast API Sales by Application (2017-2022) & (Tons)
Table 57. Europe Roflumilast API Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Roflumilast API Sales by Country (2017-2022) & (Tons)
Table 59. Middle East & Africa Roflumilast API Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Roflumilast API Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Roflumilast API Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Roflumilast API Sales by Purity (2017-2022) & (Tons)
Table 63. Middle East & Africa Roflumilast API Sales Market Share by Purity (2017-2022)
Table 64. Middle East & Africa Roflumilast API Sales by Application (2017-2022) & (Tons)
Table 65. Middle East & Africa Roflumilast API Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Roflumilast API
Table 67. Key Market Challenges & Risks of Roflumilast API
Table 68. Key Industry Trends of Roflumilast API
Table 69. Roflumilast API Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Roflumilast API Distributors List
Table 72. Roflumilast API Customer List
Table 73. Global Roflumilast API Sales Forecast by Region (2023-2028) & (Tons)
Table 74. Global Roflumilast API Sales Market Forecast by Region
Table 75. Global Roflumilast API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Roflumilast API Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Roflumilast API Sales Forecast by Country (2023-2028) & (Tons)
Table 78. Americas Roflumilast API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Roflumilast API Sales Forecast by Region (2023-2028) & (Tons)
Table 80. APAC Roflumilast API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Roflumilast API Sales Forecast by Country (2023-2028) & (Tons)
Table 82. Europe Roflumilast API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Roflumilast API Sales Forecast by Country (2023-2028) & (Tons)
Table 84. Middle East & Africa Roflumilast API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Roflumilast API Sales Forecast by Purity (2023-2028) & (Tons)
Table 86. Global Roflumilast API Sales Market Share Forecast by Purity (2023-2028)
Table 87. Global Roflumilast API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 88. Global Roflumilast API Revenue Market Share Forecast by Purity (2023-2028)
Table 89. Global Roflumilast API Sales Forecast by Application (2023-2028) & (Tons)
Table 90. Global Roflumilast API Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Roflumilast API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Roflumilast API Revenue Market Share Forecast by Application (2023-2028)
Table 93. Huateng Pharma Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 94. Huateng Pharma Roflumilast API Product Offered
Table 95. Huateng Pharma Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 96. Huateng Pharma Main Business
Table 97. Huateng Pharma Latest Developments
Table 98. Chongqing Huapont Pharmaceutical Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 99. Chongqing Huapont Pharmaceutical Roflumilast API Product Offered
Table 100. Chongqing Huapont Pharmaceutical Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 101. Chongqing Huapont Pharmaceutical Main Business
Table 102. Chongqing Huapont Pharmaceutical Latest Developments
Table 103. Interquim SA Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 104. Interquim SA Roflumilast API Product Offered
Table 105. Interquim SA Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 106. Interquim SA Main Business
Table 107. Interquim SA Latest Developments
Table 108. Veranova Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 109. Veranova Roflumilast API Product Offered
Table 110. Veranova Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 111. Veranova Main Business
Table 112. Veranova Latest Developments
Table 113. ALP Pharm Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 114. ALP Pharm Roflumilast API Product Offered
Table 115. ALP Pharm Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 116. ALP Pharm Main Business
Table 117. ALP Pharm Latest Developments
Table 118. Aspire Lifesciences Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 119. Aspire Lifesciences Roflumilast API Product Offered
Table 120. Aspire Lifesciences Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 121. Aspire Lifesciences Main Business
Table 122. Aspire Lifesciences Latest Developments
Table 123. Aurobindo Pharma Limited Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 124. Aurobindo Pharma Limited Roflumilast API Product Offered
Table 125. Aurobindo Pharma Limited Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 126. Aurobindo Pharma Limited Main Business
Table 127. Aurobindo Pharma Limited Latest Developments
Table 128. Glenmark Pharmaceuticals Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 129. Glenmark Pharmaceuticals Roflumilast API Product Offered
Table 130. Glenmark Pharmaceuticals Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 131. Glenmark Pharmaceuticals Main Business
Table 132. Glenmark Pharmaceuticals Latest Developments
Table 133. MSN Laboratories Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 134. MSN Laboratories Roflumilast API Product Offered
Table 135. MSN Laboratories Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 136. MSN Laboratories Main Business
Table 137. MSN Laboratories Latest Developments
Table 138. Melody Healthcare Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 139. Melody Healthcare Roflumilast API Product Offered
Table 140. Melody Healthcare Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 141. Melody Healthcare Main Business
Table 142. Melody Healthcare Latest Developments
Table 143. Mylan Inc Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 144. Mylan Inc Roflumilast API Product Offered
Table 145. Mylan Inc Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 146. Mylan Inc Main Business
Table 147. Mylan Inc Latest Developments
Table 148. Torrent Pharmaceuticals Basic Information, Roflumilast API Manufacturing Base, Sales Area and Its Competitors
Table 149. Torrent Pharmaceuticals Roflumilast API Product Offered
Table 150. Torrent Pharmaceuticals Roflumilast API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 151. Torrent Pharmaceuticals Main Business
Table 152. Torrent Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Roflumilast API
Figure 2. Roflumilast API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Roflumilast API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Roflumilast API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Roflumilast API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.98
Figure 10. Product Picture of 0.99
Figure 11. Product Picture of Others
Figure 12. Global Roflumilast API Sales Market Share by Purity in 2021
Figure 13. Global Roflumilast API Revenue Market Share by Purity (2017-2022)
Figure 14. Roflumilast API Consumed in Medical Pharmaceutical
Figure 15. Global Roflumilast API Market: Medical Pharmaceutical (2017-2022) & (Tons)
Figure 16. Roflumilast API Consumed in Scientific Research
Figure 17. Global Roflumilast API Market: Scientific Research (2017-2022) & (Tons)
Figure 18. Global Roflumilast API Sales Market Share by Application (2017-2022)
Figure 19. Global Roflumilast API Revenue Market Share by Application in 2021
Figure 20. Roflumilast API Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Roflumilast API Revenue Market Share by Company in 2021
Figure 22. Global Roflumilast API Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Roflumilast API Revenue Market Share by Geographic Region in 2021
Figure 24. Global Roflumilast API Sales Market Share by Region (2017-2022)
Figure 25. Global Roflumilast API Revenue Market Share by Country/Region in 2021
Figure 26. Americas Roflumilast API Sales 2017-2022 (Tons)
Figure 27. Americas Roflumilast API Revenue 2017-2022 ($ Millions)
Figure 28. APAC Roflumilast API Sales 2017-2022 (Tons)
Figure 29. APAC Roflumilast API Revenue 2017-2022 ($ Millions)
Figure 30. Europe Roflumilast API Sales 2017-2022 (Tons)
Figure 31. Europe Roflumilast API Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Roflumilast API Sales 2017-2022 (Tons)
Figure 33. Middle East & Africa Roflumilast API Revenue 2017-2022 ($ Millions)
Figure 34. Americas Roflumilast API Sales Market Share by Country in 2021
Figure 35. Americas Roflumilast API Revenue Market Share by Country in 2021
Figure 36. United States Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Roflumilast API Sales Market Share by Region in 2021
Figure 41. APAC Roflumilast API Revenue Market Share by Regions in 2021
Figure 42. China Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Roflumilast API Sales Market Share by Country in 2021
Figure 49. Europe Roflumilast API Revenue Market Share by Country in 2021
Figure 50. Germany Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Roflumilast API Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Roflumilast API Revenue Market Share by Country in 2021
Figure 57. Egypt Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Roflumilast API Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Roflumilast API in 2021
Figure 63. Manufacturing Process Analysis of Roflumilast API
Figure 64. Industry Chain Structure of Roflumilast API
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)